disodium,(6Z)-8-[2-[2-methyl-4-(3-methylphenyl)phenyl]hydrazinyl]-5-oxo-6-[(E)-(1-oxo-4-sulfonatonaphthalen-2-ylidene)hydrazinylidene]naphthalene-1-sulfonate

Names

[ Name ]:
disodium,(6Z)-8-[2-[2-methyl-4-(3-methylphenyl)phenyl]hydrazinyl]-5-oxo-6-[(E)-(1-oxo-4-sulfonatonaphthalen-2-ylidene)hydrazinylidene]naphthalene-1-sulfonate

[Synonym ]:
C.I. Direct Violet 28
C.I. Direct Violet 28,disodium salt

Chemical & Physical Properties

[ Molecular Formula ]:
C₃₄H₂₄N₄Na₂O₈S₂

[ Molecular Weight ]:
726.68600

[ Exact Mass ]:
726.08300

[ PSA ]:
221.06000

[ LogP ]:
10.48860

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :: QK2250000

CHEMICAL NAME :: 1-Naphthalenesulfonic acid, 4-hydroxy-3-((4'-((1-hydroxy-5-sulfo-2-naphthalenyl)a zo)- 3,3'-dimethyl(1,1'-biphenyl)-4-yl)azo)-, disodium salt

CAS REGISTRY NUMBER :: 6420-06-0

LAST UPDATED :: 198910

DATA ITEMS CITED :: 1

MOLECULAR FORMULA :: C34-H26-N4-O8-S2.2Na

MOLECULAR WEIGHT :: 728.74

WISWESSER LINE NOTATION :: L66J BQ ESWO CNUNR B1 DR C1 DNUN- CL66J BQ GSWO &-NA- 2

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Subcutaneous

DOSE :: 150 mg/kg

SEX/DURATION :: female 7-9 day(s) after conception

TOXIC EFFECTS :: Reproductive - Specific Developmental Abnormalities - Central Nervous System Reproductive - Specific Developmental Abnormalities - eye/ear Reproductive - Specific Developmental Abnormalities - musculoskeletal system

REFERENCE :: ANREAK Anatomical Record. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1906/08- Volume(issue)/page/year: 118,369,1954